These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 1888624)

  • 1. A comparison of drug protein binding and alpha 1-acid glycoprotein concentration in Chinese and Caucasians.
    Feely J; Grimm T
    Br J Clin Pharmacol; 1991 May; 31(5):551-2. PubMed ID: 1888624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in plasma binding of drugs between Caucasians and Chinese subjects.
    Zhou HH; Adedoyin A; Wilkinson GR
    Clin Pharmacol Ther; 1990 Jul; 48(1):10-7. PubMed ID: 2369804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interethnic differences in drug protein binding and alpha 1 acid glycoprotein concentration.
    Hosseine SJ; Farid R; Ghalighi MR; Feely J
    Ir J Med Sci; 1995 Jan; 164(1):26-7. PubMed ID: 7890529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of disopyramide, methadone, dipyridamole, chlorpromazine, lignocaine and progesterone to the two main genetic variants of human alpha 1-acid glycoprotein: evidence for drug-binding differences between the variants and for the presence of two separate drug-binding sites on alpha 1-acid glycoprotein.
    Hervé F; Duché JC; d'Athis P; Marché C; Barré J; Tillement JP
    Pharmacogenetics; 1996 Oct; 6(5):403-15. PubMed ID: 8946472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The plasma protein binding of basic drugs.
    Routledge PA
    Br J Clin Pharmacol; 1986 Nov; 22(5):499-506. PubMed ID: 3790398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered plasma drug binding in cancer: role of alpha 1-acid glycoprotein and albumin.
    Jackson PR; Tucker GT; Woods HF
    Clin Pharmacol Ther; 1982 Sep; 32(3):295-302. PubMed ID: 7105620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma protein binding of lidocaine and warfarin in insulin-dependent and non-insulin-dependent diabetes mellitus.
    O'Byrne S; Barry MG; Collins WC; O'Connor P; Cullen MJ; Feely J
    Clin Pharmacokinet; 1993 Feb; 24(2):183-6. PubMed ID: 8453825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A comparison of alpha 1-acid glycoprotein (AAG) concentration and disopyramide binding in Chinese and Japanese].
    Jin EZ
    Hokkaido Igaku Zasshi; 1999 Jul; 74(4):279-88. PubMed ID: 10480035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. alpha 1-Acid glycoprotein and plasma lidocaine binding.
    Shand DG
    Clin Pharmacokinet; 1984 Jan; 9 Suppl 1():27-31. PubMed ID: 6705424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severity of cirrhosis and the relationship of alpha 1-acid glycoprotein concentration to plasma protein binding of lidocaine.
    Barry M; Keeling PW; Weir D; Feely J
    Clin Pharmacol Ther; 1990 Mar; 47(3):366-70. PubMed ID: 2311337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interethnic scaling of fraction unbound of a drug in plasma and volume of distribution: an analysis of extrapolation from Caucasians to Chinese.
    Yu G; Zhou HH; Zheng QS; Li GF
    Eur J Clin Pharmacol; 2019 Apr; 75(4):543-551. PubMed ID: 30569284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of 1-anilino-8-naphthalene sulfonate as a fluorescent probe in the investigation of drug interactions with human alpha-1-acid glycoprotein and serum albumin.
    Essassi D; Zini R; Tillement JP
    J Pharm Sci; 1990 Jan; 79(1):9-13. PubMed ID: 2313585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding characteristics of KNI-272 to plasma proteins, a new potent tripeptide HIV protease inhibitor.
    Kiriyama A; Nishiura T; Ishino M; Yamamoto Y; Ogita I; Kiso Y; Takada K
    Biopharm Drug Dispos; 1996 Dec; 17(9):739-51. PubMed ID: 8968527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lidocaine plasma protein binding.
    Routledge PA; Barchowsky A; Bjornsson TD; Kitchell BB; Shand DG
    Clin Pharmacol Ther; 1980 Mar; 27(3):347-51. PubMed ID: 7357791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction between human serum albumin and alpha 1-acid glycoprotein in the binding of lidocaine to purified protein fractions and sera.
    Krauss E; Polnaszek CF; Scheeler DA; Halsall HB; Eckfeldt JH; Holtzman JL
    J Pharmacol Exp Ther; 1986 Dec; 239(3):754-9. PubMed ID: 3795040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lignocaine disposition in blood in epilepsy.
    Routledge PA; Stargel WW; Finn AL; Barchowsky A; Shand DG
    Br J Clin Pharmacol; 1981 Nov; 12(5):663-6. PubMed ID: 7332731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human alpha-1-glycoprotein and its interactions with drugs.
    Israili ZH; Dayton PG
    Drug Metab Rev; 2001 May; 33(2):161-235. PubMed ID: 11495502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A free lignocaine index as a guide to unbound drug concentration.
    Routledge PA; Lazar JD; Barchowsky A; Stargel WW; Wagner GS; Shand DG
    Br J Clin Pharmacol; 1985 Dec; 20(6):695-8. PubMed ID: 4092000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha1-acid glycoprotein concentration and protein binding in trauma.
    Edwards DJ; Lalka D; Cerra F; Slaughter RL
    Clin Pharmacol Ther; 1982 Jan; 31(1):62-7. PubMed ID: 7053306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the role of alpha 1-acid glycoprotein in lignocaine accumulation following myocardial infarction.
    Barchowsky A; Shand DG; Stargel WW; Wagner GS; Routledge PA
    Br J Clin Pharmacol; 1982 Mar; 13(3):411-5. PubMed ID: 7059443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.